BE897883A - Acide azetidinyl sulfonique et analogues a action therapeutique - Google Patents

Acide azetidinyl sulfonique et analogues a action therapeutique

Info

Publication number
BE897883A
BE897883A BE0/211621A BE211621A BE897883A BE 897883 A BE897883 A BE 897883A BE 0/211621 A BE0/211621 A BE 0/211621A BE 211621 A BE211621 A BE 211621A BE 897883 A BE897883 A BE 897883A
Authority
BE
Belgium
Prior art keywords
analogs
sulfonic acid
therapeutic action
hydrogen atom
azetidinyl
Prior art date
Application number
BE0/211621A
Other languages
English (en)
Inventor
W A Slusarchyk
D R Kronenthal
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of BE897883A publication Critical patent/BE897883A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Beta-lactames portant un substituant (R5,R6,O, C SO3H) en position 1 et un substituant acylamine en position 3. Ils répondant à la formule (I), dans laquelle R1 est un radical acyle, un atome d'hydrogène ou un groupement protecteur de la fonction amine, R2 est un atome d'hydrogène ou un radical méthoxy, R3, R4, R5, et R6 sont identiques ou différents et sont chacun, de préférence, un atome d'hydrogène ou un radical alkyle inférieur. Ces composés sont utilisables comme agents antibactériens.
BE0/211621A 1982-10-06 1983-09-30 Acide azetidinyl sulfonique et analogues a action therapeutique BE897883A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43317582A 1982-10-06 1982-10-06

Publications (1)

Publication Number Publication Date
BE897883A true BE897883A (fr) 1984-03-30

Family

ID=23719123

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/211621A BE897883A (fr) 1982-10-06 1983-09-30 Acide azetidinyl sulfonique et analogues a action therapeutique

Country Status (27)

Country Link
JP (1) JPS5988462A (fr)
KR (1) KR900005132B1 (fr)
AU (1) AU568312B2 (fr)
BE (1) BE897883A (fr)
CA (1) CA1253501A (fr)
CH (1) CH658858A5 (fr)
DD (1) DD222016A5 (fr)
DE (1) DE3336262A1 (fr)
DK (1) DK457983A (fr)
ES (1) ES8504814A1 (fr)
FI (1) FI833631A (fr)
FR (1) FR2534253B1 (fr)
GB (1) GB2129428B (fr)
GR (1) GR79704B (fr)
HU (1) HU190507B (fr)
IE (1) IE56600B1 (fr)
IL (1) IL69917A (fr)
IT (1) IT1171722B (fr)
LU (1) LU85033A1 (fr)
NL (1) NL8303410A (fr)
NO (1) NO833626L (fr)
NZ (1) NZ205642A (fr)
PH (1) PH24175A (fr)
PT (1) PT77458B (fr)
SE (1) SE8305509L (fr)
SU (1) SU1318146A3 (fr)
ZA (1) ZA837491B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004876A1 (fr) * 1984-04-24 1985-11-07 Takeda Chemical Industries, Ltd. Derives de 2-azetidinone et leur procede de preparation
EP0135194A1 (fr) * 1983-09-16 1985-03-27 Takeda Chemical Industries, Ltd. Azétidinones et leur préparation
US4581170A (en) * 1984-08-03 1986-04-08 E. R. Squibb & Sons, Inc. N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
EP0171064B1 (fr) * 1984-08-06 1995-07-12 Fujisawa Pharmaceutical Co., Ltd. Dérivés de l'azétidinone et procédé pour leur préparation
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates

Also Published As

Publication number Publication date
SU1318146A3 (ru) 1987-06-15
IE56600B1 (en) 1991-10-09
JPS5988462A (ja) 1984-05-22
NO833626L (no) 1984-04-09
GR79704B (fr) 1984-10-31
SE8305509L (sv) 1984-04-07
PH24175A (en) 1990-03-22
ZA837491B (en) 1984-06-27
GB2129428B (en) 1986-03-19
DK457983A (da) 1984-04-07
DK457983D0 (da) 1983-10-04
IL69917A (en) 1987-10-20
DD222016A5 (de) 1985-05-08
PT77458B (en) 1986-02-26
FI833631A0 (fi) 1983-10-06
CA1253501A (fr) 1989-05-02
DE3336262A1 (de) 1984-04-12
IE832354L (en) 1984-04-06
CH658858A5 (fr) 1986-12-15
AU1993983A (en) 1984-04-12
FR2534253A1 (fr) 1984-04-13
FR2534253B1 (fr) 1985-07-26
KR900005132B1 (ko) 1990-07-20
AU568312B2 (en) 1987-12-24
KR840006337A (ko) 1984-11-29
HU190507B (en) 1986-09-29
ES526282A0 (es) 1985-04-16
IT1171722B (it) 1987-06-10
IT8323172A0 (it) 1983-10-06
PT77458A (en) 1983-11-01
FI833631A (fi) 1984-04-07
GB2129428A (en) 1984-05-16
NL8303410A (nl) 1984-05-01
IL69917A0 (en) 1984-01-31
NZ205642A (en) 1986-08-08
ES8504814A1 (es) 1985-04-16
LU85033A1 (fr) 1984-05-10
SE8305509D0 (sv) 1983-10-06
GB8326626D0 (en) 1983-11-09

Similar Documents

Publication Publication Date Title
US4302465B1 (fr)
FR2439790A1 (fr) Phosphinylalcanoyl prolines a action therapeutique, et leurs procedes de preparation
FI823923L (fi) Antifibrinolytiskt aktiva foereningar
BE905109A (fr) Derives de distamycine et leur procede de fabrication.
MY101614A (en) Improvements in or relating to benzothiophene derivatives as antiasthmatic agents
FR2449682A1 (fr) Derives d'acide quinoleine-carboxylique et leur utilisation en tant qu'agents antimicrobiens
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
BE897883A (fr) Acide azetidinyl sulfonique et analogues a action therapeutique
FR2387989A1 (fr) Analogues des alcaloides de l'ergot
FR2456765A1 (fr) Composes iminoisoindoliniques, leur procede de preparation et leur application comme pigments
FR2445330A1 (fr) Derives du 11-bromo-14,15-dioxo-e-homo-eburnane leur preparation et leur utilisation comme medicament
DK67384D0 (da) N-iminopyridiniumbetainderivater
FR2361351A1 (fr) Intermediaires de preparation d'homologues de somatostatine
FR2447375A1 (fr) Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant
FR2428045A1 (fr) Derives silyles de naphtacenones utilisables notamment dans la synthese d'agents antitumeurs
FR2592648A1 (fr) Composes polyfluoroalkylthio-methyliques, leurs procedes de preparation et leurs applications comme agents tensio-actifs ou precurseurs de ces derniers.
FR2411173A1 (fr) Anthranilates de n-hydroxyalkyl-carboxamides et leur application comme reticulants
DK422183A (da) Fremgangsmaade til fremstilling af 5-halogenvinyl-2'-deoxyuridinderivater
FR2446284A1 (fr) Tetrahydro-benzo(c)quinoleine-9(8h)ones
FR2603284A1 (fr) Derives d'acide 7-oxabicyclo(2.2.1.)heptane hydroxamique a action therapeutique
ES8304578A1 (es) Procedimiento para preparar derivados de la ergolina.
FR2410640A1 (fr) Derives de phenoxyalcanolamines, leur preparation et leurs utilisations therapeutiques
FR2424912A1 (fr) Derives de l'imidazole utilisables notamment pour le traitement de l'hypertension
BE900718A (fr) Nouveaux derives du carbapeneme, leur preparation et leur utilisation comme medicaments.
ES535903A0 (es) Procedimiento de preparacion de derivados de nitrosoureas

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: E.R. SQUIBB & SONS INC.

Effective date: 19930930